Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:816 (21 April), doi:10.1136/bmj.39185.688819.DB
Janice Hopkins Tanne
New York
| The first 150 words of the full text of this article appear below. |
A new prospective cohort study adds to the evidence that regularly taking aspirin reduces the incidence of cancers and cancer mortality. But the study, in postmenopausal women in the US Midwest, found that use of non-steroidal anti-inflammatory drugs did not protect against cancer.
Researchers from the Mayo Clinic College of Medicine in Rochester, Minnesota, and the University of Minnesota in Minneapolis studied 22 507 postmenopausal women who had no history of cancer or heart disease and who took part in the Iowa women's health study. They presented their findings in an abstract at the annual meeting of the American Association for Cancer Research in Los Angeles last week (www.abstractsonline.com/viewer/searchAdvanced.asp, abstract 3400).
When the women enrolled in the study in 1992, they reported their use of aspirin and non-steroidal anti-inflammatory drugs and also their smoking history. The researchers did not question the women further but determined cancer incidence and
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses